The good news: Corona is coming to India with a stronger drug than Remedicivir


BanglaHunt Desk: The whole world is fighting over COVIED-19. NovaLead Pharma, a pharmaceutical company in India, was then allowed to test the final phase of an effective drug, more potent than hydroxychloroquine, for the treatment of corona. The Pune-based drug manufacturer has already received approval from the Drug Controller General of India (DCGI) for a final stage clinical trial of the drug (NLP21).

Sudhir Kulkarni, head of the research team for the drug (NLP21) at the institute, said the drug would be applied experimentally to 100 to 150 corona patients undergoing treatment at the hospital. This drug (NLP21) will be applied to those who have respiratory problems and need to take oxygen. However, the drug (NLP21) will not be applied to patients who are already on ventilation, said Sudhir Kulkarni. However, the drug (NLP21) will also help reduce the risk of virus infection in the body of a patient on ventilation, the company claims.

According to the agency, the drug has been used in the treatment of multiple viral diseases for the past several years. Novalid Pharma claims that this drug (NLP21) has no side effects.

The company said it would complete all tests on the drug (NLP21) in the next 3-4 months. The company claims that this drug (NLP21) will help prevent corona infections as well as reduce the 'viral load' on the body of the infected person. Not only that, but tests in multiple laboratories in South Korea and the United States have shown that this drug (NLP21) is much more potent and effective in the treatment of corona than remedicivir, lopinavir, ritonavir, hydroxychloroquine.

Experts hope that the experimental success of this drug made by Novalid Pharma will make India's fight against corona much easier. If the final trial of this drug (NLP21) is successful, the drug company in Pune may start commercial production by October.